Trial of Trastuzumab Deruxtecan in Previously Treated HER2
NCT06750484
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Metastatic
Interventions
DRUG:
Trastuzumab Deruxtecan
Sponsor
Yale University
Collaborators
[object Object]
[object Object]